Saul Kivimäe

1.8k total citations
24 papers, 1.4k citations indexed

About

Saul Kivimäe is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Saul Kivimäe has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Saul Kivimäe's work include Wnt/β-catenin signaling in development and cancer (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer-related gene regulation (4 papers). Saul Kivimäe is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (6 papers), Glycosylation and Glycoproteins Research (4 papers) and Cancer-related gene regulation (4 papers). Saul Kivimäe collaborates with scholars based in United States, Norway and Estonia. Saul Kivimäe's co-authors include Francis C. Szoka, Benjamin Cheyette, Lino Sáez, Michael W. Young, Simon Lee, Aaron Dolor, Hideaki Okochi, Vincent J. Venditto, Rowena Suriben and Jean M. J. Fréchet and has published in prestigious journals such as Nature Genetics, Journal of Neuroscience and Blood.

In The Last Decade

Saul Kivimäe

24 papers receiving 1.4k citations

Peers

Countries citing papers authored by Saul Kivimäe

Since Specialization

Citations

This map shows the geographic impact of Saul Kivimäe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul Kivimäe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul Kivimäe more than expected).

Fields of papers citing papers by Saul Kivimäe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saul Kivimäe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul Kivimäe. The network helps show where Saul Kivimäe may publish in the future.

Co-authorship network of co-authors of Saul Kivimäe

This figure shows the co-authorship network connecting the top 25 collaborators of Saul Kivimäe. A scholar is included among the top collaborators of Saul Kivimäe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saul Kivimäe. Saul Kivimäe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bempegaldesleukin (BEMPEG; NKTR‐214) efficacy as a single agent and in combination with checkpoint‐inhibitor therapy in mouse models of osteosarcoma 2020 ·International Journal of Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), Vikas Kundra, Murali K. Ravoori, John Stewart, Eugenie S. Kleinerman, V. Behrana Jensen, Vidya Gopalakrishnan, Rhoneil Pena, (unknown), Grace Kim, Saul Kivimäe, Loui Madakamutil, Willem W. Overwijk, Jonathan Zalevsky, Nancy Gordon	11
2	REVEAL: A phase I/II, open-label, multicenter, dose escalation and dose expansion study of NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] with or without nivolumab (nivo) in patients (pts) with locally advanced or metastatic solid tumor malignancies 2018 ·Annals of Oncology ·Adi Diab, (unknown), Mary Tagliaferri, Ute Hoch, (unknown), Werner Rubas, Saul Kivimäe, Jonathan Zalevsky, Anthony P. Conley, Erkut Borazanci, Sandra P. D’Angelo	5
3	Clodronate Improves Survival of Transplanted Hoxb8 Myeloid Progenitors with Constitutively Active GMCSFR in Immunocompetent Mice 2017 ·Molecular Therapy — Methods & Clinical Development ·Simon Lee, Saul Kivimäe, Francis C. Szoka	5
4	Macrophage-based cell therapies: The long and winding road 2016 ·Journal of Controlled Release ·Simon Lee, Saul Kivimäe, Aaron Dolor, Francis C. Szoka	155
5	DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/β-catenin signaling 2016 ·Molecular Psychiatry ·(unknown), Robert Stanley, (unknown), Andiara E. Freitas, (unknown), Audrey C. Brumback, Jillian Iafrati, (unknown), Sara L. Domínguez, Saul Kivimäe, Kimberly Mulligan, Mehdi Pirooznia, W. Richard McCombie, James B. Potash, Peter P. Zandi, Shaun Purcell, Stephan Sanders, Yi Zuo, Vikaas S. Sohal, Benjamin Cheyette	45
6	The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes 2015 ·Journal of Controlled Release ·Paul H. Kierstead, Hideaki Okochi, Vincent J. Venditto, (unknown), Saul Kivimäe, Jean M. J. Fréchet, Francis C. Szoka	158
7	Delivery of Lipid Micelles into Infarcted Myocardium Using a Lipid-Linked Matrix Metalloproteinase Targeting Peptide 2015 ·Molecular Pharmaceutics ·Juliane Nguyen, Richard E. Sievers, J. P. Michael Motion, Saul Kivimäe, Qizhi Fang, Randall J. Lee	33
8	Improving the distribution of Doxil® in the tumor matrix by depletion of tumor hyaluronan 2014 ·Journal of Controlled Release ·Aditya Kohli, Saul Kivimäe, Matthew Tiffany, Francis C. Szoka	74
9	Chemoenzymatic Synthesis of Oligohyaluronan–Lipid Conjugates 2014 ·Bioconjugate Chemistry ·(unknown), Saul Kivimäe, Francis C. Szoka	15
10	Glucose Sensor O-GlcNAcylation Coordinates with Phosphorylation to Regulate Circadian Clock 2013 ·Cell Metabolism ·Krista Kaasik, Saul Kivimäe, Jasmina J. Allen, Robert J. Chalkley, Yong Huang, Kristin Baer, Holger Kissel, Alma L. Burlingame, (unknown), Louis J. Ptáček, Ying‐Hui Fu	205
11	Abnormal behavior in mice mutant for the Disc1 binding partner, Dixdc1 2011 ·Translational Psychiatry ·Saul Kivimäe, (unknown), David Kapfhamer, Youlin Ruan, Ulrike Heberlein, John L.R. Rubenstein, (unknown)	19
12	All Dact (Dapper/Frodo) scaffold proteins dimerize and exhibit conserved interactions with Vangl, Dvl, and serine/threonine kinases 2011 ·BMC Biochemistry ·Saul Kivimäe, (unknown), Benjamin Cheyette	30
13	Dact1 Is a Postsynaptic Protein Required for Dendrite, Spine, and Excitatory Synapse Development in the Mouse Forebrain 2010 ·Journal of Neuroscience ·Nathan D. Okerlund, Saul Kivimäe, Cheuk Ka Tong, I‐Feng Peng, Erik M. Ullian, Benjamin Cheyette	25
14	Dact1–3 mRNAs exhibit distinct expression domains during tooth development 2010 ·Gene Expression Patterns ·Päivi Kettunen, Saul Kivimäe, (unknown), Ophir D. Klein, Benjamin Cheyette, Keijo Luukko	13
15	Posterior malformations in Dact1 mutant mice arise through misregulated Vangl2 at the primitive streak 2009 ·Nature Genetics ·Rowena Suriben, Saul Kivimäe, Daniel A.C. Fisher, Randall T. Moon, Benjamin Cheyette	70
16	Activating PER Repressor through a DBT-Directed Phosphorylation Switch 2008 ·PLoS Biology ·Saul Kivimäe, Lino Sáez, Michael W. Young	69
17	DACT3 Is an Epigenetic Regulator of Wnt/β-Catenin Signaling in Colorectal Cancer and Is a Therapeutic Target of Histone Modifications 2008 ·Cancer Cell ·Xia Jiang, Jing Tan, Jingsong Li, Saul Kivimäe, Xiaojing Yang, Li Zhuang, Puay Leng Lee, (unknown), Lawrence W. Stanton, Edison T. Liu, Benjamin Cheyette, Qiang Yu	201
18	Three Dact gene family members are expressed during embryonic development and in the adult brains of mice 2006 ·Developmental Dynamics ·Daniel A.C. Fisher, Saul Kivimäe, (unknown), Rowena Suriben, Pierre‐Marie Martin, (unknown), Benjamin Cheyette	64
19	Posttranscriptional and Posttranslational Regulation of Clock Genes 2004 ·Journal of Biological Rhythms ·(unknown), Saul Kivimäe, Michael W. Young, Lino Sáez	141
20	Replication of a chimeric origin containing elements from Epstein–Barr virus ori P and bovine papillomavirus minimal origin 2001 ·Virus Research ·Saul Kivimäe, (unknown), Reet Kurg, Mart Ustav	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact